AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/article-1G1-202438586/your-clinician-prescribing-under.html" title="Facts and information about Is your clinician prescribing under the influence?">Is your clinician prescribing under the influence?</a>
Close
Set up an RSS feed that alerts you when new articles from Women's Health Activist are available.
Frequently asked questions about RSS feeds
Is your clinician prescribing under the influence?
Here's a fun way for your favorite clinician to learn how drug companies try to influence them--and earn Continuing Medical Education (CME) credits at the same time. The Pharmalyzer CME course offers open-minded clinicians a chance to see themselves through the eyes of Big Pharma, specifically Big Pharma's salespeople. It uses drug companies' own words, gathered from marketing journals, training manuals, and testimony of former drug sales reps. Once physicians see themselves as they're viewed by drug companies, they're better able to resist sales pitches and turn to unbiased sources of information ...
Related articles from newspapers, magazines, journals, and more
For more facts and information, see all results
- Financial and Strategic Analysis of the Sales Outlook for Big Pharma, Mid...
- Press release article from: Business Wire February 12, 2007 700+ words
...Strategic Analysis of the Sales Outlook for Big Pharma, Mid Pharma, Japan Pharma and Biotech...Analysis of the Sales Outlook to 2011 for Big Pharma, Mid Pharma, Japan Pharma and Biotech...Highlights Faced with failing growth, Big Pharma is expected to pursue strategic options...
- Key Challenges and Issues Facing the Pharmaceutical Company Outlook to 2012:...
- Press release article from: Business Wire January 20, 2008 700+ words
...Strategic Analysis of the Sales Outlook for Big Pharma, Mid Pharma, Japan Pharma and Biotech...of-the-Sales-Outlook-for-Big- Pharma-Mid-Pharma-Japan-Pharma-and...Analysis of the Sales Outlook to 2012 for Big Pharma, Mid Pharma, Japan Pharma and Biotech...
- A Comprehensive Big Pharma M&A Analysis to 2012 - Surveying the Growth Rate...
- Press release article from: M2 Presswire October 13, 2008 700+ words
...Research and Markets: A Comprehensive Big Pharma M&A Analysis to 2012 - Surveying...researchandmarkets.com/research/fa352c/big_pharma_ma_ana) has announced the addition of the "Big Pharma M&A Analysis to 2012 - Surveying...
- A Comprehensive Big Pharma M&A Analysis to 2012 - Surveying the Growth Rate...
- Press release article from: Business Wire October 13, 2008 700+ words
...researchandmarkets.com/research/ed3063/big_pharma_ma_ana) has announced the addition of the "Big Pharma M&A Analysis to 2012 - Surveying...to fall below their historic levels, Big Pharma must act to bolster its performance out...
- BIO-EUROPE 2007 AS BIG PHARMA MODEL FALTERS, BIOTECH RIDES TO THE RESCUE.
- Magazine article from: BIOWORLD Today Harris, Glen November 13, 2007 700+ words
...BIO-Europe 2007. "What is it about big pharma that allows the strong to become weak...produced no vehement rebuttals even from big pharma representatives at Monday's panel on...have a high innovation environment at a big pharma," he said. "It's hard for me to...
- "Big Pharma' Turns To Biologics For Growth To 2010: Financial And Strategic...
- Press release article from: M2 Presswire June 5, 2006 700+ words
...PRESSWIRE-5 June 2006-MindBranch: "Big Pharma' Turns To Biologics For Growth To 2010...Financial And Strategic Segmentation Of The 'Big Pharma' Sector By Drug Technology" by Datamonitor...COMMUNICATIONS LTD RDATE:02062006 'Big Pharma' (non-biotech companies with annual...
- As blockbusters fade, Big Pharma "must change or perish," warns US analyst.
- Newspaper article from: Pharma Marketletter January 3, 2005 700+ words
...business model of blockbuster drugs used by Big Pharma needs to be revisited, Sander Flaum...formularies will be tighter after 2005. For Big Pharma it is "change or perish," he said...margins and little competition, he said. Big Pharma has changed its tactics before and will...
- Hired hands: biotechs that combine forces with well-established big pharma...
- Magazine article from: Medical Marketing & Media Collado, Roland November 1, 2006 700+ words
...common alternative--negotiating with "big pharma" to share sales force time--can compromise...While many biotech executives have big-pharma experience, most have worked with sales...There are pluses to this strategy. The big-pharma logo on the business card, for example...
